Sol-Gel Technologies (NASDAQ:SLGL) Issues Quarterly Earnings Results
Sol-Gel Technologies reported a quarterly earnings per share of ($2.13), missing analysts' estimates of ($2.09). The company had a negative net margin of 14.25% and a negative return on equity of 11.80%. Revenue for the quarter was $0.40 million, exceeding the expected $0.30 million. Shares traded down 2.6% to $35.09. Analysts have given the stock a consensus rating of 'Hold' with a target price of $50.00.
Sol-Gel Technologies (NASDAQ:SLGL - Get Free Report) announced its quarterly earnings results on Thursday. The company reported ($2.13) EPS for the quarter, missing the consensus estimate of ($2.09) by ($0.04), Zacks reports. The firm had revenue of $0.40 million for the quarter, compared to analysts' expectations of $0.30 million. Sol-Gel Technologies had a negative return on equity of 11.80% and a negative net margin of 14.25%.
Get Sol-Gel Technologies alerts:
Sol-Gel Technologies Trading Down 2.6%
Shares of NASDAQ SLGL traded down $0.95 during midday trading on Thursday, reaching $35.09. 19,061 shares of the stock were exchanged, compared to its average volume of 22,531. The stock has a 50 day moving average price of $33.95 and a 200-day moving average price of $19.45. The company has a market capitalization of $97.76 million, a P/E ratio of -28.53 and a beta of 1.35. Sol-Gel Technologies has a 52-week low of $4.02 and a 52-week high of $52.26.
Wall Street Analyst Weigh In
SLGL has been the topic of a number of research analyst reports. HC Wainwright boosted their target price on Sol-Gel Technologies from $6.00 to $50.00 and gave the stock a "buy" rating in a research report on Monday, October 27th. Weiss Ratings restated a "hold (c-)" rating on shares of Sol-Gel Technologies in a research report on Wednesday, October 8th. Wall Street Zen lowered shares of Sol-Gel Technologies from a "buy" rating to a "hold" rating in a research report on Saturday, November 1st. Finally, Zacks Research raised shares of Sol-Gel Technologies to a "hold" rating in a research note on Tuesday, October 28th. One equities research analyst has rated the stock with a Buy rating and two have issued a Hold rating to the company's stock. According to data from MarketBeat, Sol-Gel Technologies presently has a consensus rating of "Hold" and a consensus target price of $50.00.
View Our Latest Stock Analysis on SLGL
About Sol-Gel Technologies
(Get Free Report)Sol-Gel Technologies Ltd., together with its subsidiary Sol-Gel Technologies Inc, develops topical dermatological drugs for patients with severe skin conditions in Israel. The company offers Twyneo, a once-daily, non-antibiotic topical cream for the treatment of acne vulgaris; and Epsolay, a once-daily topical cream for the treatment of papulopustular (subtype II) rosacea.
Recommended Stories
- Five stocks we like better than Sol-Gel Technologies
- How to Know if a Stock Pays Dividends and When They Are Paid Out
- NVIDIA Just Proved the AI Boom Is Bigger Than Anyone Thought
- How to find penny stocks to invest and trade
- Why Target Stock May Keep Falling Despite a 5% Dividend Yield
- What Does a Gap Up Mean in Stocks? How to Play the Gap
- Is Tesla Setting Up for a Year-End Rebound—or a Collapse?
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Should You Invest $1,000 in Sol-Gel Technologies Right Now?
Before you consider Sol-Gel Technologies, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Sol-Gel Technologies wasn't on the list.
While Sol-Gel Technologies currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
